November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
Melissa Young, MD: Should Primary Care be More Involved in Diabetes Management?
August 10th 2020An endocrinologist from New Jersey reflects on whether or not the management of type 2 diabetes should fall under the umbrella of primary care specialists rather than endocrinologists as diabetes become more prevalent.